If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
FENTANYL JUNO fentanyl (as citrate) 500 microgram/10 mL injection ampoule AUST R: 384588Active ingredients:
fentanyl citrate
Dosage form:
Injection, solution
Sponsor:
Juno Pharmaceuticals Pty Ltd
Phone:
0388881288
|
From
30 May 2025
to
30 Jun 2025
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
Alternative generic products are available.
|
FENTANYL JUNO fentanyl (as citrate) 100 microgram/2 mL injection ampoule AUST R: 384587Active ingredients:
fentanyl citrate
Dosage form:
Injection, solution
Sponsor:
Juno Pharmaceuticals Pty Ltd
Phone:
0388881288
|
From
12 Aug 2024
to
31 Jan 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
NAROPIN 0.2% WITH FENTANYL 200 microgram/100mL ropivacaine hydrochloride 2mg/mL and fentanyl 2 microgram/mL (as citrate) 100mL injection bag AUST R: 72874Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
20 Mar 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|
NAROPIN 0.2% WITH FENTANYL 400 microgram/100mL ropivacaine hydrochloride 2 mg/mL and fentanyl 4 microgram/mL (as citrate) 100ml injection bag AUST R: 72876Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
06 Feb 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|
NAROPIN 0.2% WITH FENTANYL 400 microgram/200mL ropivacaine hydrochloride 2 mg/mL and fentanyl 2 microgram/mL (as citrate) 200mL injection bag AUST R: 72873Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300
|
Deletion from market:
01 May 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|
NAROPIN 0.2% WITH FENTANYL 800 microgram/200mL ropivacaine hydrochloride 2 mg/mL and fentanyl 4 microgram/mL (as citrate) 200mL injection bag AUST R: 72875Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
06 Feb 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|